These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35342902)

  • 1. Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential.
    Yang Y; Zeng C; Yang K; Xu S; Zhang Z; Cai Q; He C; Zhang W; Liu SM
    Extracell Vesicles Circ Nucl Acids; 2022; 3(1):49-60. PubMed ID: 35342902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
    Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
    Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
    Chu JL; Bi SH; He Y; Ma RY; Wan XY; Wang ZH; Zhang L; Zheng MZ; Yang ZQ; Du LW; Maimaiti Y; Biekedawulaiti G; Duolikun M; Chen HY; Chen L; Li LL; Tie L; Lin J
    Front Endocrinol (Lausanne); 2022; 13():910907. PubMed ID: 35966076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.
    Cai J; Zeng C; Hua W; Qi Z; Song Y; Lu X; Li D; Zhang Z; Cui X; Zhang X; Yang Z; Zhang J; Quan K; Zhu W; Cai J; He C; Cheng SY; Zhang W; Mao Y
    Neurooncol Adv; 2021; 3(1):vdab049. PubMed ID: 34151267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma.
    Chiu BC; Zhang Z; Derman BA; Karpus J; Luo L; Zhang S; Langerman SS; Sukhanova M; Bhatti P; Jakubowiak A; He C; Zhang W
    J Hematol Oncol; 2022 Aug; 15(1):106. PubMed ID: 35974364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations before the application of 5-hydroxymethylation levels of long non-coding RNAs for non-invasive cancer diagnosis.
    Zhang Z; Zeng C; Zhang W
    Extracell Vesicles Circ Nucl Acids; 2022; 3(1):10-13. PubMed ID: 35098258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
    Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
    Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
    J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
    Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
    Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients.
    Al-Kafaji G; Aljadaan A; Kamal A; Bakhiet M
    Exp Ther Med; 2018 Aug; 16(2):1483-1492. PubMed ID: 30116398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
    Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
    Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma.
    Chiu BC; Chen C; You Q; Chiu R; Venkataraman G; Zeng C; Zhang Z; Cui X; Smith SM; He C; Zhang W
    NPJ Genom Med; 2021 Feb; 6(1):11. PubMed ID: 33574286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.
    Al-Kafaji G; Al-Mahroos G; Al-Muhtaresh HA; Skrypnyk C; Sabry MA; Ramadan AR
    Exp Ther Med; 2016 Aug; 12(2):815-822. PubMed ID: 27446281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma.
    Zeng C; Zhang Z; Wang J; Chiu BC; Hou L; Zhang W
    Epigenomes; 2019 Sep; 3(3):. PubMed ID: 31413874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.
    Li S; Wang Y; Wen C; Zhu M; Wang M; Cao G
    Front Cell Dev Biol; 2022; 10():845641. PubMed ID: 35399499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and Epigenetics of Diabetic Nephropathy.
    Liu R; Lee K; He JC
    Kidney Dis (Basel); 2015 May; 1(1):42-51. PubMed ID: 27536664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients.
    Coskun ZM; Ersoz M; Adas M; Hancer VS; Boysan SN; Gonen MS; Acar A
    Arch Med Res; 2019 Apr; 50(3):91-97. PubMed ID: 31495395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.